Drugmaker AstraZeneca is drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is being viewed as an option, the Financial Times reported on Sunday. ( read original story ...)
Stock market today: Asia follows Wall St lower as US, Chinese foreign ministers meet
BEIJING (AP) — Asian stock markets followed Wall Street lower Monday after the top U.S. and Chinese diplomats agreed to cooperate during a meeting held at a time of friction over an array of conflicts ... ( read original story ...)
Shanghai Stock Volatility Will Slow Chinese Listing Trend
The turbulence in the Shanghai stock market is causing Chinese companies listed on U.S. exchanges to think twice before moving their tickers back to mainland China. The turbulence in the Shanghai ... ( read original story ...)
A China-based bank that’s trying to de-dollarize global lending is now having trouble repaying its dollar debts, report says
The New Development Bank is having difficulty accessing dollars, and has largely stopped lending, the Wall Street Journal reported. ( read original story ...)
Shanghai DZH’s Controller Sells USD25.1 Million Shares to Pay Firm’s Compensation to Investors
The actual controller of Shanghai DZH, which supplies internet financial information services, sold CNY179 million (USD25.1 million) of its shares to fund the firm’s compensation to investors over ... ( read original story ...)
China Stock Market May Test Resistance At 3,300 Points
The China stock market has alternated between positive and negative finishes through the last four trading days since the end of the ( read original story ...)
Shanghai releases action plan targeting high-end manufacturing sector, semiconductor, biomedicine and AI industry size to reach 1.8 tln yuan by 2025
Shanghai also plans to foster around 15 new manufacturing enterprises with an annual production value of 10 billion yuan. Furthermore, the plan aims to facilitate initial public offerings (IPOs) for ... ( read original story ...)